ArticleJournal of experimental & clinical cancer research : CR2025

JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer.

Sarah Alexandrou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.